Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

boehringer ingelheim international gmbh - tiotropium - inhalation powder, hard capsule - 18 microgram(s) - anticholinergics; tiotropium bromide

Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

merit pharmaceuticals limited - tiotropium bromide - inhalation powder, hard capsule - 18 microgram(s) - anticholinergics; tiotropium bromide

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

boehringer ingelheim (nz) limited - tiotropium bromide monohydrate 3.125ug equivalent to tiotropium 2.5 µg/dose - solution for inhalation - 2.5 mcg/dose - active: tiotropium bromide monohydrate 3.125ug equivalent to tiotropium 2.5 µg/dose excipient: benzalkonium chloride disodium edetate hydrochloric acid purified water - spiriva respimat is indicated for the long term once daily maintenance treatment of bronchospasm and dyspnoea associated with chronic obstructive pulmonary disease (copd), including chronic bronchitis and emphysema. spiriva reduces the frequency of exacerbations and improves exercise tolerance and health-related quality of life.

Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

boehringer ingelheim international gmbh - tiotropium - inhalation solution - 2.5 microgram(s) - anticholinergics; tiotropium bromide

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - tiotropium bromide monohydrate, quantity: 3.1235 microgram/actuation (equivalent: tiotropium, qty 2.5 microgram/actuation) - inhalation, conventional - excipient ingredients: purified water; hydrochloric acid; disodium edetate; benzalkonium chloride - copd: srivasso respimat is indicated for the long term maintenance treatment of bronchospasm and dyspnoea associated with chronic obstructive pulmonary disease (copd). srivasso respimat is indicated for the prevention of copd exacerbations.,asthma: srivasso respimat is indicated as add-on maintenance bronchodilator treatment in patients aged 6 years and older with moderate to severe asthma.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - tiotropium bromide monohydrate, quantity: 3.1235 microgram/actuation (equivalent: tiotropium, qty 2.5 microgram/actuation) - inhalation, conventional - excipient ingredients: purified water; hydrochloric acid; disodium edetate; benzalkonium chloride - copd: esovynd respimat is indicated for the long term maintenance treatment of bronchospasm and dyspnoea associated with chronic obstructive pulmonary disease (copd). esovynd respimat is indicated for the prevention of copd exacerbations.,asthma: esovynd respimat is indicated as add-on maintenance bronchodilator treatment in patients aged 6 years and older with moderate to severe asthma.

Singapor - Ingliż - HSA (Health Sciences Authority)

boehringer ingelheim singapore pte. ltd. - olodaterol hydrochloride eqv olodaterol; tiotropium bromide monohydrate eqv tiotropium - solution - olodaterol hydrochloride eqv olodaterol 0.0025 mg/actuation; tiotropium bromide monohydrate eqv tiotropium 0.0025 mg/actuation

Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

imed healthcare ltd. - tiotropium - inhalation solution - 2.5 microgram(s) - tiotropium bromide

Ingilterra - Ingliż - myHealthbox

boehringer ingelheim international gmbh - tiotropium (as bromide monohydrate), olodaterol (as hydrochloride) - inhalation solution - 2.5 microgram/2.5 microgram per puff - drugs for obstructive airway diseases, adrenergics in combination with anticholinergics - it is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd)

Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

boehringer ingelheim international gmbh - tiotropium; olodaterol - inhalation solution - 2.5 µg/2.5 microgram(s) - anticholinergics; anticholinergics - drugs for obstructive airway diseases, adrenergics in combination with anticholinergics - it is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).